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Abstract
Background In primary care, fee-for-services (FFS) tar-
iffs are often based on political negotiation rather than
costing systems. The potential for comprehensive measures
of patient morbidity to explain variation in negotiated FFS
expenditures has not previously been examined.
Objectives To examine the relative explanatory power of
morbidity measures and related general practice (GP) clinic
characteristics in explaining variation in politically nego-
tiated FFS expenditures.
Methods We applied a multilevel approach to consider
factors that explain FFS expenditures among patients and
GP clinics. We used patient morbidity characteristics such
as diagnostic markers, multimorbidity casemix adjustment
based on resource utilisation bands (RUB) and related GP
clinic characteristics for the year 2010. Our sample inclu-
ded 139,527 patients visiting GP clinics.
Results Out of the individual expenditures, 31.6 % were
explained by age, gender and RUB, and around 18 % were
explained by RUB. Expenditures increased progressively
with the degree of resource use (RUB0–RUB5). Adding
more patient-specific morbidity measures increased the
explanatory power to 44 %; 3.8–9.4 % of the variation in
expenditures was related to the GP clinic in which the
patient was treated.
Conclusions Morbidity measures were significant
patient-related FFS expenditure drivers. The association
between FFS expenditure and morbidity burden appears to
be at the same level as similar studies in the hospital sector,
where fees are based on average costing. However, our
results indicate that there may be room for improvement of
the association between politically negotiated FFS expen-
ditures and morbidity in primary care.
Keywords General practice  Expenditure variation 
Resource utilisation band (RUB)  Fee-for-services (FFS) 
The Johns Hopkins Adjusted Clinical Groups (ACG)
system
JEL Classification D61  H51  I120  I180
Introduction
As is the case in many western countries, Denmark is
expected to face an increasing morbidity burden because of
lifestyle changes, demographic development and increased
life spans among the elderly population [1, 2]. In line with
this development several countries—but so far not Den-
mark—have changed the resource allocation systems for
sicknesses towards morbidity-based case mix adjustment
systems [3]. One such system is the Johns Hopkins
Adjusted Clinical Groups (ACG) system, which measures
an individual’s health status and health care needs [4, 5].
This system has demonstrated robustness in its ability to
measure morbidity burdens in individuals and populations
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[3, 4]. For instance, studies based on the ACG classification
have shown that an individual’s health care expenditures
are correlated with the patient’s total morbidity burden
instead of the particular disease a patient may have [6–8].
Thus, orienting resource allocation systems toward
patients’ overall health care needs appears to be a prom-
ising approach that could be used to make risk adjustment
of primary care reimbursement systems [7].
However, in contrast to a morbidity-based case mix
adjustment, it may be claimed that unadjusted reimburse-
ment systems based on FFS expenditures are associated
with patient morbidity characteristics because of supple-
mentary fees for additional services. Moreover, the FFS
component of a mixed GP remuneration system such as
Denmark’s could be viewed as a way to reward GPs with
complex patients, hence making the morbidity risk
adjustment redundant [9].
More evidence regarding the relationship between
expenditures for FFS remuneration and patient morbidity
characteristics is relevant when deciding whether to adopt a
morbidity-based case mix system as part of the GP remu-
neration system [3]. Today, numerous county councils in
Sweden have implemented a morbidity-based case mix
system for resource allocation in primary care [3, 10, 11].
In Denmark, there is no explicit differentiation between per
capita fees or FFS according to morbidity status. However,
many Danish GPs have used the International Classifica-
tion of Primary Care code (ICPC-2) for several years and
the use is increasing [12, 13]. Simultaneously, the Danish
Quality Unit of General Practice (DAK-E) has imple-
mented the routine electronic collection of ICPC-2 diag-
noses for episodes of care. These new and unique data offer
an opportunity to examine the relationship between the
way in which current expenditures for FFS remuneration
are allocated and patient morbidity characteristics.
The aim of this study was to use resource utilisation
bands (RUBs) based on the ACG case mix system and
diagnostic markers to investigate how well patient-level
measures of morbidity burden and related GP clinic char-
acteristics explained patient-level variability in the FFS
expenditures of patients receiving treatment in Danish GP
clinics.
The structure of the article is as follows. First we give a
brief introduction to the Danish primary care setting and
the remuneration of GPs. Then we describe the methods
and data used. Next, the results are presented and dis-
cussed, and a conclusion is given.
The Danish context and the remuneration of GPs
In Denmark, there are approximately 5.5 million inhabit-
ants, 3,500 GPs and 2,200 GP clinics. Nearly all Danes
(98 %) are listed with a specific GP, who is responsible for
serving the patients on his/her list, which on average yields
approximately 1,600 patients per GP [14]. GPs are self-
employed professionals who contract with the five regions
that have the overall operational and planning responsi-
bilities for the health care system [15]. In contrast to other
countries, for instance, Sweden, where the majority of GP
clinics are public, the organisation as independent busi-
nesses has implied that there is a lack of public data about
the actual costs in Danish GP clinics [16]. GP services are
financed by taxes and the five regions receive block grants
from the central government for operational expenditures
such as FFS expenditures. There are no user charges on GP
services, with the exception of several special services such
as particular vaccinations and certificates for drivers’
licenses.
Denmark operates a mixed remuneration system in
which GPs act as gate-keepers to the rest of the health care
system [14, 15, 17]. The GPs are compensated by the
regions through a combination of per capita fees (30 %)
and FFS (70 %) [16]. FFS are applied to promote activity
and productivity and to provide incentives for the GPs to
treat patients themselves rather than to refer the patients to
hospitals. Per capita fees should reduce the temptation for
GPs to provide unnecessary treatments and should com-
pensate GPs for services not remunerated by FFS. The idea
is to strike an effective balance between per capita payment
and FFS [14]. FFS fees for GPs are negotiated by the
Danish Regions’ Board for Wages and Tariffs and the
Danish Organisation of General Practitioners (PLO) and
used politically to create incentives for specific services.
Risk adjusters such as age and gender are not used in
defining fees or to differentiate the per capita component at
clinic level. There are no fees for coding of diagnoses; the
only incentive for GPs to code diagnoses is to promote
better organisation and quality development in their own
clinics [12, 13]. The mixed remuneration system is cur-
rently undergoing a restructuring process [14]. Among
other considerations, the prevailing opinion is that the FFS
component is too dominant.
Methods
A two-stage multilevel regression approach was used to
explain per patient FFS expenditure [18–21]. We postu-
lated that FFS expenditure at the patient level was associ-
ated with demographics, patient morbidity measures and
related GP clinic characteristics. Thus, we assessed whe-
ther the FFS system prompts the GPs to provide services
according to morbidity burden. Our dependent variable was
defined as the annual expenditures for the FFS remunera-
tion of patient i. These annual patient-level FFS expendi-
tures (FFSEi) are the sum of GP services (sik) weighted by
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politically negotiated fees for each service (pk). Hence, the
dependent variable was indicated as follows:
FFSEi ¼
XK
k¼1
pksik ð1Þ
where FFSEi is influenced by politically negotiated fees
(pk), but not directly linked to patients’ morbidity burden
[14]. This representation indicates that we are analysing
patient expenditure based on underlying GP revenue eco-
nomics rather than on the costs related to GP patients.
Following Eq. 1, important economic incentives for GPs to
provide more services include relatively higher fees or
additional fees for supplementary services.
In the first stage of our analysis we applied a fixed-
effects multilevel data model that recognises the stratifi-
cation of patients within GP clinics. The model takes the
following form:
FFSEij ¼ a þ xijb1 þ uj þ vij; i ¼ 1; . . .; I;
j ¼ 1; . . .; N: ð2Þ
where FFSEij represents FFS expenditures for patient
i listed with a GP clinic j. Patients were identified using the
patient’s personal identification number. xij is a row vector
of explanatory variables containing morbidity characteris-
tics, the age and gender of patient i in GP clinic j, and uj is
the GP clinic-specific effect referring to the conditional
mean of the annual expenditures per individual treated by
GP clinic j. This GP fixed effect captures the relative
average of a GP clinic’s FFS expenditures after allowing
for differences in patient characteristics [21]. vij is the
normal residual, which was assumed to be normally dis-
tributed with a zero mean and a constant variance. Our
analytical approach is based on the underlying assumption
that GP clinics share the same behavioural expenditure
function. In contrast to previous studies on hospital
departments using similar approaches [18, 21], we believe
that Danish GP clinics are more homogeneous; hence, the
assumption is less restrictive.
Simplified morbidity categories based on ACGs, known
as resource utilisation bands (RUB), were used to measure
the patients’ illness burdens [5, 11, 22]. Moreover, the ACG
system software was used to assign a six-level morbidity-
based RUB measure as follows: 0, non-users; 1, healthy
users; 2, low morbidity; 3, moderate; 4, high, 5: very high
[22]. The six RUBs are formed by combining the ACGs in
mutually exclusive cells that measure the overall morbidity
burden. The ACG system appears to be particularly useful
for ambulatory care, where physicians offer comprehensive
and continuous care to a defined list of patients [23].
To explore the sensitivity of results to different diag-
nostic characteristics, we specified six first-stage multilevel
models (1A–6A) with different combinations of five
subsets of covariates: the age and sex of the patient, the
groupings of ACGs (version 9.0) into RUBs, two sets of
diagnostic markers based on the International Classifica-
tion of Primary Care (ICPC-2), and the number of visits
and number of diagnoses of the patient [24]. One set of
diagnostic markers was based on 17 types of body systems/
problem areas (i.e., symptoms and/or conditions) according
to the ICPC-2 classification (see Table 1). Another set was
based on the classification of ICPC-2 diagnoses into seven
chapter components that were identical throughout all of
the chapters (i.e., components that distinguish symptoms,
diagnoses, work and care processes). The latter set of
diagnostic markers was process codes, symptoms/com-
plaints, infections, neoplasms, injuries, congenital anoma-
lies and other diagnoses [25]. Process codes are non-
symptom-related reasons for encounters, such as child
investigations, vaccinations and prophylactic health
checks. The symptoms marker (#01–#29) contains reasons
for encounters in chapters (A–Z), whereas the infections,
neoplasms, injuries, congenital anomalies and other diag-
nostic (#70-#99) markers cover specific conditions. A set
of demographic variables (age and gender) expected to
influence expenditures is present in all of the models (1–6)
in Eq. 2. To measure the prevalence of symptoms/condi-
tions per patient in each ICPC-2 classification, and to
measure the variation explained by the diversity of mor-
bidity or multimorbidity rather than by volume, we
excluded the volume of particular diagnoses from the two
sets of diagnostic markers in Eq. 2 and analysed the range
of different diagnoses per patient. This approach is in line
with the RUB/ACG algorithm that is based on the range of
illnesses rather than on the volume [3–5]. To address the
excluded volume of diagnoses and visits, the number of
diagnoses recorded per patient and the number of visits per
patient were included in model 6. Overall, the decompo-
sition approach where the volume was excluded (models
1–5) and re-included (model 6) allowed us to disentangle
the variation into variation explained by diversity of mor-
bidity and volume aspects, respectively. Likelihood ratio
test statistics and Akaike’s information criterion (AIC)
were used to compare the fit of the five nested models and
to choose a model for the second stage.
In the second stage, after controlling for patient char-
acteristics, we regressed the estimated fixed effects uˆj (GP
clinic average FFS expenditures) from Eq. 2 against a set
of GP clinic characteristics to reveal the extent to which the
GP-specific FFS expenditure variation was explained by
observable GP clinic characteristics. Our equation takes the
following form:
u^j ¼ k þ zjb2 þ ej; ð3Þ
where zj is a vector of covariates describing the charac-
teristics of each GP clinic j, and ej is assumed to be
Morbidity burden in primary care
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normally distributed with zero mean and constant variance.
uˆj measures the estimated GP clinic-specific deviation for
GP clinic j. We included the number of physicians per GP
clinic based on the supposition that if there were revenue
economies of scale [26], then the annual expenditures per
patient would increase as the size of the clinic in terms of
Table 1 Descriptive sentinel patient characteristics
Mean p5 p50 p95
Expenditures in euro (€) 145.648 17,34 92,57 459,41
Non-diagnostic markers
Age (years) 42.854 5 44 80
Sex (male = 0, female = 1) 0.559 0 1 1
Number of visits 4.115 0 3 12
Number of diagnoses 4.782 0 3 15
Morbidity markers based on RUBs
Resource utilisation band 0–5 1.868 0 2 3
RUB0 0.159
RUB1 0.167
RUB2 0.339
RUB3 0.318
RUB4 0.016
RUB5 0.001
Prevalence Number of diagnoses
p75 p95 p99
Diagnostic markers based on ICPC-2 chapters
General and Unspecified, A01–A99 0.308 1 2 5
Blood, Blood Forming Organs and Immune Mechanism, B01–B99 0.027 0 0 2
Digestive, D01–D99 0.125 0 1 4
Eye, F01–F99 0.046 0 0 1
Ear, H01–H99 0.071 0 1 2
Cardiovascular, K01–K99 0.191 0 4 8
Musculoskeletal, L01–L99 0.279 1 3 7
Neurological, N01–N99 0.108 0 1 4
Psychological, P01–P99 0.077 0 1 5
Respiratory, R01–R99 0.267 1 3 6
Skin, S01–S99 0.253 1 2 5
Endocrine/Metabolic and Nutritional, T01–T99 0.137 0 3 8
Urological, U01–U99 0.072 0 1 4
Pregnancy, Childbearing, Family Planning, W01–W99 0.057 0 1 3
Female Genital, X01–X99 0.099 0 1 3
Male Genital, Y01–Y99 0.030 0 0 1
Social Problems, Z01–Z29 0.014 0 0 1
Diagnostic chapter components markers
PROCESS CODES 0.222 0 2 4
SYMPTOMS/COMPLAINTS 0.536 2 5 11
INFECTIONS 0.312 1 3 6
NEOPLASMS 0.032 0 0 2
INJURIES 0.105 0 1 3
CONGENITAL ANOMALIES 0.026 0 0 1
OTHER DIAGNOSES 0.494 2 8 16
p5 5 % percentile, p50 50 % percentile, p75 75 % percentile, p95 95 % percentile, p99 99 % percentile
T. Kristensen et al.
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number of physicians increased. We also controlled for the
average physician age, the proportion of female physicians,
the proportion of patient sex and patient age proportions,
because FFS expenditure might be influenced by these
clinic characteristics.
For instance, there may be shifts in the volume of ser-
vices provided by GPs of different ages [27]. Female
physicians are expected to be more likely to have longer
consultations, work fewer hours and manage different
types of medical conditions [28, 29], and the variability of
GP clinic activity is believed to be associated with the
patient sex proportion and age group proportions [30]. The
patient age (proportion 19–67) was used as a reference
group for the proportions of younger and older patients.
Finally, we explored whether the GP clinic fixed effects
were associated with the proportion of multimorbidity
(RUBs) and proportions of specific diagnostic markers. For
instance, management or detection of psychiatric problems
may be associated with consultation length in GP clinics
[31, 32].
The standard errors in Eq. 2 were corrected for hetero-
scedasticity using White’s procedure to ensure that statis-
tical tests were valid. To ensure that our second-stage
estimates were not contaminated by heteroscedasticity
from the first-stage analysis, Eq. 3 was estimated using
Efron robust standard errors [33]. All analyses were per-
formed with the use of the software package STATA
version 12.0 (Stata Corp., College Station, TX, USA).
Data
To be able to monitor the activity and conduct research in
the GP sector, DAK-E has defined a database of sentinel
GP clinics and their sentinel patients [13]. Sentinel GP
clinics are clinics that, on average, coded more than 70 %
of their patients for at least 6 months and continued to do
so within 1 year. Patients were excluded if they changed to
a non-sentinel GP clinic.
We analysed the FFS expenditures of GP care for
139,527 sentinel patients who were representative of
Danish GP patients and were registered and received ser-
vices in 59 sentinel GP clinics in 2010. Our analysis
combined several data sets: (1) the Danish General Practice
Database (DAMD), which includes data (such as the ICPC-
2 diagnosis and use of GP services from the National
Health Insurance Service Registry) linked to the patient’s
personal identification number [34]; (2) ACGs with similar
expenditures grouped by resource utilisation band (RUB);
(3) the tariff agreement on GP services between the PLO
and the Association of Danish Regions.
ACGs were grouped into one of six different RUBs to
reduce the number of homogeneous categories [22]. RUB 0
indicates little or no need, whereas RUB 5 indicates a very
large need for resources. Recent studies confirmed that
there is a relationship between RUBs and actual costs in
primary care [3, 8, 11, 35, 36].
The tariff agreement on GP services and the National
Health Service disbursement codes were used to calculate
and map service expenditure data for each patient in 2010.
Thus, we were able to identify the GP expenditures of
primary care patients for 2010. Figure 1 plots these
expenditures, with each dot representing an individual
patient and the y-axis showing the expenditures for every
patient in each of the 59 GP clinics. The overall average
FFS expenditures for primary care patients in 2010 were
€145.6 (p5 = 17.3; p95 = 459.4).
Descriptive sentinel patient and GP clinic
characteristics
Table 1 contains five subsets of sentinel patient character-
istics: non-diagnostic markers, morbidity markers based on
RUB, diagnostic markers based on ICPC-2 chapters, diag-
nostic chapter component markers and volume markers. We
describe the 139,527 patients using means, percentiles and
prevalence of diagnostic markers. Table 2 shows four sub-
sets of GP clinic characteristics: non-diagnostic character-
istics, RUB proportions, ICPC-2 chapter proportions and
ICPC-2 chapter component proportions. We portray the 59
sentinel GP clinics using means, standard deviations (SD),
coefficients of variation (Cv) and percentiles.
Results
Table 3 shows the results of estimating Eq. 2 using the five
specifications that include different sets of diagnostic
factors.
Fig. 1 Patient fee-for-service expenditures by GP clinics
Morbidity burden in primary care
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These models are able to explain upwards of
13.3–79.3 % of the variation in the FFS expenditures for
primary care patients in sentinel GP clinics, as indicated
by the overall R2 statistic. Model 1 includes demographic
case mix adjusters, and models 2–5 differ according to
combinations of three sets of morbidity-based case mix
Table 2 GP clinic characteristics
Mean SD Cv p5 p95
Expenditures in euro (€) per patient 145.957 30.116 0.206 101.798 195.920
Non-diagnostic characteristics
Number of physicians 2.390 1.508 0.631 1 6
Average physician age 53.56 7.667 0.143 42 66
Proportion of female physicians 0.508 0.354 0.696 0 1
Patient sex (proportion female) 0.557 0.048 0.085 0.488 0.644
Patient age (proportion 0–18) 0.202 0.046 0.226 0.101 0.268
Patient age (proportion 19–67) 0.623 0.059 0.095 0.521 0.741
Patient age (proportion 68?) 0.175 0.058 0.333 0.088 0.279
Resource utilisation band proportions
RUB0 0.144 0.069 0.481 0.043 0.280
RUB1 0.159 0.033 0.204 0.101 0.227
RUB2 0.335 0.027 0.081 0.284 0.369
RUB3 0.342 0.086 0.253 0.209 0.495
RUB4 0.018 0.014 0.765 0.003 0.046
RUB5 0.002 0.002 1.234 0.000 0.007
RUB1–5 1.936 0.263 0.136 1.475 2.393
ICPC-2 chapter proportions
General and Unspecified A 0.316 0.111 0.351 0.097 0.623
Blood, Blood Forming Organs and Immune Mechanism B 0.031 0.022 0.712 0.004 0.113
Digestive D 0.130 0.039 0.304 0.064 0.229
Eye F 0.047 0.023 0.497 0.015 0.125
Ear H 0.073 0.023 0.314 0.035 0.126
Cardiovascular K 0.206 0.063 0.307 0.091 0.362
Musculoskeletal L 0.290 0.064 0.222 0.168 0.451
Neurological N 0.116 0.035 0.300 0.045 0.202
Psychological P 0.085 0.032 0.376 0.016 0.189
Respiratory R 0.273 0.056 0.203 0.171 0.420
Skin S 0.258 0.062 0.240 0.133 0.387
Endocrine/Metabolic and Nutritional T 0.151 0.063 0.415 0.024 0.340
Urological U 0.080 0.028 0.353 0.035 0.160
Pregnancy, Childbearing, Family Planning W 0.059 0.020 0.332 0.021 0.135
Female Genital X 0.104 0.032 0.311 0.040 0.201
Male Genital Y 0.034 0.018 0.517 0.007 0.100
Social Problems Z 0.014 0.013 0.885 0.000 0.077
ICPC-2 chapter component proportions
PROCESS CODES 0.223 0.134 0.603 0.000 0.606
SYMPTOMS/COMPLAINTS 0.553 0.101 0.183 0.376 0.751
INFECTIONS 0.319 0.072 0.225 0.153 0.470
NEOPLASMS 0.035 0.017 0.483 0.011 0.086
INJURIES 0.106 0.043 0.408 0.028 0.229
CONGENITAL ANOMALIES 0.027 0.012 0.448 0.006 0.078
OTHER DIAGNOSES 0.520 0.103 0.198 0.308 0.751
SD standard deviation, Cv coefficient of variation, p5 5 % percentile, p95 95 % percentile
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adjusters and diagnostic markers: (1) RUB case mix
adjusters, (2) diagnostic markers based on ICPC-2 body
system chapters ‘A–Z’ and (3) diagnostic markers based
on ICPC-2 chapter components. Finally, model 6 incor-
porates the number of visits per patient and the number of
diagnoses per patient.
Table 3 First stage estimates: variation in FFSE due to patient characteristics and GP clinic fixed effect, 2010
Model 1 Model 2 Model 3 Model 4 Model 5 Model 6
Demographic markers
Age (years) -0.607*** -1.339*** -0.820*** -0.809*** -0.764*** -0.670***
Age squared 0.0348*** 0.0314*** 0.0211*** 0.0252*** 0.0203*** 0.0146***
Sex 24.21*** 14.75*** 3.950*** 6.695*** 3.423*** 1.900***
RUB markers
RUB1 34.17*** -12.77*** -22.01*** -21.36*** 0.781
RUB2 76.36*** 0.117 1.147 -11.13*** 5.876***
RUB3 185.7*** 35.84*** 71.57*** 21.91*** 15.69***
RUB4 356.8*** 109.1*** 208.8*** 93.95*** 20.81***
RUB5 446.9*** 141.0*** 288.0*** 127.7*** 24.25***
ICPC-2 chapter markers
General and Unspecified A 45.39*** 28.16*** -4.034***
Blood, Blood For. B 60.73*** 57.66*** 2.927*
Digestive D 36.82*** 32.19*** -7.482***
Eye F 14.05*** 5.814*** -10.54***
Ear H 25.40*** 18.66*** -11.17***
Cardiovascular K 68.21*** 62.62*** 9.423***
Musculoskeletal L 25.84*** 19.80*** -17.39***
Neurological N 47.77*** 44.70*** 7.694***
Psychological P 81.37*** 77.47*** 38.08***
Respiratory R 47.35*** 37.85*** 1.660**
Skin S 35.93*** 24.89*** -10.78***
Endocrine/Metab. T 106.8*** 101.6*** 46.65***
Urological U 71.97*** 64.63*** 13.54***
Pregnancy, Childb. W 61.44*** 53.68*** 19.76***
Female Genital X 22.60*** 11.95*** -14.72***
Male Genital Y 25.12*** 21.39*** -6.589***
Social Problems Z 36.59*** 36.76*** 12.94***
Chapter components markers
PROCESS CODES 54.63*** 27.33*** 19.93***
SYMPTOMS/COMPLAINTS 44.49*** 11.18*** -2.467***
INFECTIONS 48.25*** 19.17*** -1.557**
NEOPLASMS 2.943 0.0540 -0.756
INJURIES 38.98*** 23.13*** 0.568
CONGENITAL ANOMALIES 10.69*** 4.132* 2.974*
OTHER DIAGNOSES 66.26*** 19.61*** 4.133***
Volume markers
Number of visits 22.06***
Number of diagnoses 5.914***
Constant 74.81*** 22.75*** 13.99*** 4.774*** 11.67*** 4.997***
N 139,527 139,527 139,527 139,527 139,527 139,527
Rho 0.0378 0.0598 0.0947 0.0695 0.0941 0.0735
R2 overall 0.133 0.316 0.437 0.372 0.444 0.793
Number of general practices 59 59 59 59 59 59
* p \ 0.05; ** p \ 0.01; *** p \ 0.001
Morbidity burden in primary care
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Demographic markers
Model 1 shows that age and sex explained 13.3 % of the
variation in FFS expenditures. For women, primary care
expenditures were higher than for men. All of the models
revealed that primary care expenditures were U-shaped
functions of age, with younger and older patients having
higher expenditures.
RUB markers
The inclusion of morbidity-based case mix adjusters (RUBs)
in model 2 increased the model’s explanatory power from
13.3 to 31.6 %. Overall, FFS expenditures increased pro-
gressively with the degree of multimorbidity. The coeffi-
cients for the RUBs were all related to the reference group
RUB0. The expenditures for patients allocated to RUB1–5
were significantly higher than for patients allocated to
RUB0. In models 3–6, the RUB coefficient decreased
because of the introduction of additional morbidity charac-
teristics (ICPC-2 chapter and component markers).
Diagnostic markers
Models 3–5 include combinations of the two sets of diag-
nostic markers, ‘ICPC-2 Chapter Markers’ and ‘Chapter
Component Markers’, and show high levels of significant
explanatory power for each of the markers. The R2 (over-
all) statistic increases from 31.6 to 43.7 % (model 3),
37.2 % (model 4) and 44.4 % (model 5). The most expensive
diagnostic marker seems to be ‘Endocrine/Metabolic and
Nutritional’ By contrast, the chapter marker ‘Eye’ appears to
be the least expensive. The only insignificant diagnostic
marker was ‘NEOPLASMS’. These patients are mainly
treated for cancer at hospitals.
Volume markers
The inclusion of the number of visits and the number of
diagnoses in model 6 increased the explanatory power from
44 to 79.3 % and changed the sign and magnitude of
several covariates, and RUB1 and ‘INJURIES’ became
insignificant. The changed signs and magnitude of the beta
coefficients in model 6 reflect the fact that some patients’
morbidity characteristics are associated with higher or
lower FFS expenditure after controlling for the volume of
activity. For instance, a ‘general and unspecified’ marker
leads to significantly lower expenditures per patient, and
‘Endocrine/Metab.’ or ‘psychiatric’ markers seem to result
in larger expenditure per patient. After adjusting for the
patient characteristics, the rho statistic in Table 3 indicated
that GP clinic characteristics explained 3.8–9.4 % of the
remaining variation in patient expenditures.
Pairwise likelihood ratio tests of all combinations of the
nested models (1–6) rejected all special cases in favour of
model 6. In addition, model 6 was the model with the
smallest AIC value.
Variation in GP clinic fixed effects due to GP clinic
characteristics (stage 2)
Table 4: In all five models, the number of physicians was
significant in explaining why FFS expenditures per patient
differ from one GP clinic to another.
A higher number of physicians lead to more expendi-
tures per patient. This finding suggests that larger clinics
have larger expenditures per patient. It is also evident that
expenditures did not vary from one clinic to another
because of differences in the average physician age. A
higher average physician age did not lead to more expen-
ditures per patient, which results in more revenue in each
clinic. Models 6A–6E show that these results were robust
to different combinations of covariates. Model 6B and 6C
indicate that a larger proportion of young patients (0–18)
imply lower expenditure per patient. In models 6D–6E,
however, this significance was transferred to ICPC-2
chapter proportions (A–Z) or ICPC-2 chapter component
proportions because of the introduction of more covariates.
Models 6D to 6E indicate that some of these proportions of
clinic morbidity characteristics are significant in explaining
FFS variation across GP clinic patients. In model 6D, the
proportion of patients with a digestive disorder is signifi-
cant in explaining the variation in FFS expenditures across
GP clinics. Other ICPC-2 chapter proportions such as
‘Psychological’ (p = 0.111), ‘Endocrine/metabolic’
(p = 0.108) and ‘Pregnancy/childbearing’ (p = 0.059)
also showed some association, but not at the 5 % level. In
model 6E, both the proportion of RUB1 and RUB3 and
several proportions of ICPC-2 chapter components were
significant expenditure drivers. A higher proportion of
patients with digestive disorder symptoms/complaints and
infection coding leads to significantly lower expenditures
per patient, and a larger proportion of congenital anomalies
seems to result in larger expenditures per patient.
Discussion
Association between FFS expenditures and morbidity
burden
Danish GP clinics receive a large part (70 %) of their
remuneration through FFS. This article analyses the associ-
ation between this negotiated FFS expenditure component of
a mixed remuneration system and the comprehensive mea-
sures of patient morbidity. Overall, we found that age, sex,
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RUBs and morbidity characteristics explained more than
40 % of the variance in FFS expenditures. This figure, when
compared with the 13.3 % obtained when only age and sex
are used, indicates that morbidity characteristics are pow-
erful when it comes to explaining annual FFS expenditures
per patient in Denmark. This limited explanatory power of
Table 4 Second stage estimates: variation in GP clinic fixed effects due to GP clinic characteristics, 2010
Model 6A Model 6B Model 6C Model 6D Model 6E
Non-diagnostic characteristics
Number of physicians 4.312*** 5.043** 4.004* 4.293* 3.880*
Average physician age -0.0775 -0.0130 -0.338 -0.464 -0.0268
Proportion of female physicians 4.747 18.65** 7.934 -0.507 4.895
Patient sex (proportion female) -52.40 -54.05 -183.0* 61.15
Patient age (proportion 0–18) -196.3** -171.4* -81.09 -97.38
Patient age (proportion 68?) -89.98* -14.07 70.15 21.83
RUB proportions
RUB1 105.1 202.3 436.0**
RUB2 -93.63 73.90 146.7
RUB3 -37.95 194.7 435.5*
RUB4 -227.6 463.4 -203.8
RUB5 -3,287.8 -2,232.3 -13.17
ICPC-2 chapter proportions
General and Unspecified A 5.555
Blood, Blood Forming Organs B -117.9
Digestive D -347.6*
Eye F -140.5
Ear H -1.156
Cardiovascular K 9.120
Musculoskeletal L -55.19
Neurological N 129.1
Psychological P -155.8
Respiratory R -56.33
Skin S -32.51
Endocrine/Metabolic T -102.6
Urological U -169.3
Pregnancy, Childbearing W 295.3
Female Genital X 133.5
Male Genital Y -147.6
Social Problems Z 135.0
Chapter component proportions
PROCESS CODES 11.56
SYMPTOMS/COMPLAINTS -165.1**
INFECTIONS -151.5**
NEOPLASMS -195.0
INJURIES 62.80
CONGENITAL ANOMALIES 463.4*
OTHER DIAGNOSES -167.9
Constant -12.61 59.63 104.5 79.10 -84.66
N 59 59 59 59 59
R2 0.124 0.285 0.576 0.761 0.721
R2 adjusted 0.0763 0.202 0.476 0.538 0.595
F 4.383 5.419 11.99 13.08 7.525
* p \ 0.05; ** p \ 0.01; *** p \ 0.001
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demographic variables is consistent with the health insur-
ance literature in which age and gender explain little of the
individual risk of incurring health expenditures [37].
The multimorbidity case mix index (RUBs) based on the
ACG system explained approximately 20 % of the variation.
Additional diagnostic markers show that expenditures are
driven by morbidity characteristics over and above their
RUB classification. The volume of visits and diagnoses
increased the explanatory power to 79 %. The significance of
the number of visits is consistent with the fact that the
standard fee for a visit is by far the most frequently used fee.
In model 6 positive beta estimates indicate that services other
than visits are supplied to patients. For example, patients
with an ‘Endocrine/Metab.’ or ‘psychological’ diagnosis
still have positive and relatively high coefficients after
controlling for number of visits. These results confirm that
diabetes patients and psychiatric patients allow for specific
and supplementary fees. RUB1 and ‘INJURIES’ become
insignificant after controlling for volume markers. The jus-
tification may be that the majority of RUB1 patients and
patients with ‘INJURIES’ visit their GP without having other
services than a standard visit. Only 3.8–9.4 % of the varia-
tion could be explained by clinic characteristics. Whereas the
former result indicates some association between resource
use (RUB) and FFS expenditures, the latter indicates that,
even if GP clinics manage patients in different ways, clinics
may have limited effects on FFS expenditures.
Recently, it was proposed that the FFS tariffs should be
reduced in favour of increased per capita fees [14]. This may
help to mitigate the possibility that patients are overserved
under FFS [9]. However, because of the estimated association
between morbidity characteristics and FFS expenditures, as
well as this proposal, there is a risk that the relationship
between patient resource use (RUB) and GP remuneration is
reduced. This risk is supported by recent research suggesting
that patients in need of a high level of medical services receive
more health benefits under FFS [9]. Finally, in the case of an
increased element of capitation, another option might be to
differentiate fixed per capita fees according to morbidity
characteristics [38–41], although increased capitation may
lead to increases in the number of underserved patients [9].
Related English and Danish studies assessing the asso-
ciation between costs and DRGs in hospital departments
using patient level data have found an explanatory power
of DRGs in the range of 30–60 % [18, 21]. Although it
may be problematic to compare across sectors, the present
association between FFS remuneration and cost (RUBs) is
approximately at the same level.
Other results of interest
To assess the relative roles of GP clinic morbidity char-
acteristics, we have adjusted for the size of the GP clinic,
the average physician age, the proportion of female phy-
sicians, patient sex and patient age proportions. Using the
number of physicians as an indicator of GP clinic size, we
found that larger GP clinics tend to have higher expendi-
tures and therefore supply more services per patient. This
finding indicates that larger GP clinics are able to organise
themselves in a way that increases their service delivery
capacity. The latter finding indicates that larger GP clinics
may be able to exploit revenue economies [26]. The
average physician age was not associated with per patient
FFS expenditure. GP clinics with higher or lower average
physician age did not have different expenditures per
patient. The latter may reflect a small variation in the age
of Danish GPs (many are nearing retirement) and related
low variability in workload behaviour. The proportion of
female physicians and the proportion of younger and older
patients showed some significance, although this signifi-
cance was transferred when increasing numbers of mor-
bidity proportions where controlled for. At the clinic level,
a higher proportion of patients with a digestive disorder,
symptoms/complaints and infections appears to lead to
significantly fewer expenditures for FFS remuneration of
patients per clinic. However, a larger proportion of con-
genital anomalies appears to result in more expenditure for
FF remuneration per patient. Altogether, these results
indicate that the remuneration for clinics with high or low
proportions of these patients may not be adequate. In
contrast to a morbidity-based distribution of regional
budgets, these results suggest that a higher proportion of
some morbidity proportions leads to a relatively lower
allocation of resources and, hence, that patients may
become underserved. These results could be interpreted as
an inappropriate and inefficient allocation of resources in
terms of patient morbidity burdens. Thus, our results
indicate that it may be desirable to take case mix systems
into account in contracts between buying agencies (the
Danish regions) and health care providers (GP clinics) to
achieve a more rational distribution of resources according
to the patients’ morbidity status and health care needs [38].
However, case mix-adjusted remuneration may imply
negative externalities in terms of strategic coding of
diagnoses.
Strengths and weaknesses
The use of patient-level data has allowed us to explore the
ways in which patient morbidity measures and related GP
clinic characteristics explain politically negotiated FFS
expenditures. Patient level analysis makes use of much
more information about patients than GP clinic-level
analysis. Sentinel GP clinics coding diagnoses for more
than 70 % of their patients are preferred for research and
monitoring [13]. The current sample of patients was
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representative of all GP patients. However, the sample of
59 sentinel GP clinics was not representative of Danish GP
clinics. In 2010, only a limited number of GPs (3–4 %)
coded sufficiently to qualify as sentinel GP clinics. Con-
sequently, the number of clinics for our second-stage
analysis was limited. A feature of the included sentinel GP
clinics is that they code diagnoses on a voluntary basis.
Thus far, no economic incentives have been agreed upon.
Nevertheless, it remains possible that the quality of diag-
nosis coding needs to be improved [42, 43]. Some sentinel
GP clinics may not have allocated enough time or resour-
ces to learn about the existing and potential benefits of the
new system. However, care should be taken when com-
bining clinical diagnoses with economic incentives; the
latter may very well distort the coding system [44].
It could be claimed that the number of diagnoses recorded
is a clinic characteristic rather than a patient characteristic
because there might be fewer FFS expenditures in clinics
where more diagnoses are coded. Within the context of an
average 7–10 min consultation, coding is thought to take
approximately 30 s per item [45]. However, we assumed that
the number of diagnoses recorded is a patient characteristic
rather than a clinic characteristic. We argue that physicians
in sentinel GP clinics have been trained in coding and that
they code more than 70 % of their patients.
The number of visits could also have been considered to
be a clinic characteristic rather than a patient characteristic
[42]. The reason is that FFS may create an incentive to
provide more care than needed and/or affect clinical
decision-making [19, 46]. Still, we argue that the number
of visits is a patient characteristic rather than an aggregated
clinic characteristic.
The log-transformation of expenditures in Eq. 2 was
tested. This transformation did not change the magnitude or
significance of the results and the interpretation of beta
coefficients became less meaningful than expenditures in
terms of €. Some clinics have very large proportions of
patients who receive an ICPC-2 ‘A’ chapter diagnosis. This
variation reflects the fact that contact with GP clinics does
not lead to specific diagnoses, for instance, because of
variability in coding behaviour and a need for general
advice on non-specific complaints [1]. Danish sentinel GP
clinics code most chronic diseases such as diabetes and
chronic obstructive pulmonary disease in a valid and reli-
able way [43]. However, our results indicate that sentinel
GP clinics code a relatively small number of cancer diag-
noses. Most cancer patients only consult their GP regarding
other symptoms/conditions and rehabilitation. These con-
tacts are probably coded with a non-specified diagnosis or
another specific diagnosis. Thus, cancer patient contacts
seem to be ‘under-coded’. In contrast to chronic diseases,
non-chronic diagnoses and RFEs are coded in a less valid
and reliable way [43].
Conclusion
Morbidity measures were significant patient-related FFS
expenditure drivers. The association between FFS expen-
diture and morbidity burdens appears to be at the same
level as similar studies in the hospital sector where fees are
based on average costing. However, our results indicate
that there may be room for improvement of the association
between politically negotiated FFS expenditures and mor-
bidity in primary care.
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